Sign In
Buy NDAQ
$81.61
-0.88 (-1.07%)
At Close: Jun 24, 2026
The Nasdaq Is Falling: 4 of the Safest Stocks to Buy Right Now
04:06am, Friday, 07'th Mar 2025
For the better part of the last 2.5 years, the bulls have been calling the shots on Wall Street. The ageless Dow Jones Industrial Average, benchmark S&P 500, and growth-dominated Nasdaq Composite (^IX
Petco Health + Wellness Company, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05:18pm, Thursday, 06'th Mar 2025
SAN DIEGO , March 6, 2025 /PRNewswire/ -- Petco Health and Wellness Company, Inc. (Nasdaq: WOOF) today announced that it has granted inducement equity awards on March 4, 2025 (the "Grant Date") to its
Graphjet Technology Discloses Notice from Nasdaq
04:30pm, Thursday, 06'th Mar 2025
Innovative technological leader to oversee all technical, operational, customer support and business development initiatives
Nasdaq falls back into correction territory as S&P 500 tests a ‘line in the sand.' Watch these levels.
02:07pm, Thursday, 06'th Mar 2025
Heavy losses for tech stocks had the Nasdaq Composite flirting with a correction, defined as a 10% drop from a recent high, as major indexes renewed a slide tied to economic jitters.
Conduit Pharmaceuticals Provides Update on Nasdaq Stock Market Hearing Panel
09:35am, Thursday, 06'th Mar 2025
NAPLES, Fla. and CAMBRIDGE, United Kingdom, March 06, 2025 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) ("Conduit Pharmaceuticals" or "Conduit" or the “Company”) announces that,
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08:00am, Thursday, 06'th Mar 2025
PARSIPPANY, N.J., March 06, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies, today announced the granting
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07:00am, Thursday, 06'th Mar 2025
RESEARCH TRIANGLE PARK, N.C., March 06, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst's board of directors granted
HCW Biologics Granted Extension by the Nasdaq Hearings Panel to Regain Compliance with Continued Listing Requirements
06:55am, Thursday, 06'th Mar 2025
MIRAMAR, Fla., March 06, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (Nasdaq: HCWB), a clinical-stage biopharmaceutical company focused on discovering and de
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
06:05pm, Wednesday, 05'th Mar 2025
LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on March 4, 2025, the Compensation Committee of Puma's Board of Directors approved th
Agios Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Corporate Development & Strategy Officer
05:52pm, Wednesday, 05'th Mar 2025
CAMBRIDGE, Mass., March 05, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate kinase (PK) activation pioneering therapies for rare disea
Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement
04:15pm, Wednesday, 05'th Mar 2025
WALTHAM, Mass., March 05, 2025 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO) today announced that it has received notice from The Nasdaq Stock Market LLC (�
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:00pm, Wednesday, 05'th Mar 2025
WESTLAKE VILLAGE, Calif., March 05, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations i
Nasdaq 100 and S&P 500: Struggling After Disappointing Jobs Data, Tariff Uncertainty
10:00am, Wednesday, 05'th Mar 2025
US stocks struggle as weak jobs data offsets tariff hopes. Nasdaq nears correction, Dow and S&P 500 flat.
Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07:00am, Wednesday, 05'th Mar 2025
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ: BCYC), today announced that on March 3, 2025, the Compensation Committee of the company's Board of Directors granted to
The Nasdaq Is in a Correction – Here Are 2 Stocks You Can Buy on Sale Right Now
05:18am, Wednesday, 05'th Mar 2025
A stock market correction is generally defined as a drop of 10% from recent highs, and the tech-heavy Nasdaq Composite just got there. The Nasdaq has been the best performing major market index for th
